172 related articles for article (PubMed ID: 31315958)
1. A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
Khan A; Rivas LM; Spencer M; Martinez R; Lam M; Rojas P; Porte L; Silva F; Braun S; Valdivieso F; Mv Lhauser M; Lafourcade M; Miller WR; García P; Arias CA; Munita JM
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315958
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
[TBL] [Abstract][Full Text] [Related]
3. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
Urbán E; Stone GG
Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of ceftaroline to MRSA isolates: a multicenter study].
Mengeloğlu FZ; Taş T; Koçoğlu E; Copur Çiçek A; Yanık K; Güneş H; Ciftci IH; Durmaz S; Bucak O; Güçkan R; Terzi HA; Yavuz MZ
Mikrobiyol Bul; 2013 Oct; 47(4):677-83. PubMed ID: 24237436
[TBL] [Abstract][Full Text] [Related]
6. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
[TBL] [Abstract][Full Text] [Related]
7. Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints.
Sachu A
Ethiop J Health Sci; 2023 Jan; 33(1):143-150. PubMed ID: 36890938
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
[TBL] [Abstract][Full Text] [Related]
10. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
[TBL] [Abstract][Full Text] [Related]
11. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
13. Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia.
Abbott IJ; Jenney AW; Jeremiah CJ; Mirčeta M; Kandiah JP; Holt DC; Tong SY; Spelman DW
Antimicrob Agents Chemother; 2015 Dec; 59(12):7837-41. PubMed ID: 26392488
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.
Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
Sader HS; Mendes RE; Jones RN; Flamm RK
Diagn Microbiol Infect Dis; 2016 Sep; 86(1):76-9. PubMed ID: 27394637
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
Antonelli A; Giani T; Coppi M; Di Pilato V; Arena F; Colavecchio OL; Conte V; Santerre Henriksen A; Rossolini GM;
J Antimicrob Chemother; 2019 Dec; 74(12):3453-3461. PubMed ID: 31652323
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS; Farrell DJ; Flamm RK; Jones RN
Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
19. Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018).
Sader HS; Jones RN
Clin Microbiol Infect; 2020 May; 26(5):658-659. PubMed ID: 31899333
[No Abstract] [Full Text] [Related]
20. Prevalence and molecular epidemiology of ceftaroline non-susceptible methicillin-resistant Staphylococcus aureus isolates, first clinical report from Iran.
Khoshbayan A; Shariati A; Ghaznavi-Rad E; van Belkum A; Darban-Sarokhalil D
Acta Microbiol Immunol Hung; 2020 Dec; 67(4):228-233. PubMed ID: 33258796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
